Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership553,290 shares
Latest Disclosed Value $ 53,807,453
Qube Research & Technologies Ltd ownership in RVMD / Revolution Medicines, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 553,290 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $53,807,453 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Revolution Medicines, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 553,290 553,290 53,807 0.0598
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 0 -786,017 -100.00 0 -100.00
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 786,017 602,877 329.19 28,918 346.59 0.0294
2025-05-15 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 183,140 -47,705 -20.67 6,476 -35.87 0.0075
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 230,845 87,771 61.35 10,097 55.63 0.0132
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 143,074 -106,114 -42.58 6,488 -32.91 0.0096
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 249,188 81,708 48.79 9,671 79.17 0.0153
2024-05-14 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 167,480 141,965 556.40 5,398 638.30 0.0086
2024-02-13 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 25,515 -192,917 -88.32 732 -87.91 0.0014
2023-11-13 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 218,432 218,432 6,046 0.0158
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.